Results 121 to 130 of about 8,519 (204)

PRMT5 inhibitors on the (myeloma) road

Oncotarget, 2018
Gulla, Annamaria, Hideshima, Teru, Anderson, Kenneth C.   +2 more
openaire   +2 more sources

Lessons from Cohort Studies of Targetable Metabolic Deficiencies in Lung Cancer. [PDF]

Clin Cancer Res
Li D, Garon EB.
europepmc   +1 more source

Analyzing the cytotoxicity and pro-tumorigenic role of acetyl tributyl citrate in prostate through network toxicology and the immune microenvironment. [PDF]

Front Immunol
Xie S, Qing M, Zhang Z, Zhang H, Zhang Y, Yang Z, Chen Z, Liang Z, A G.   +8 more
europepmc   +1 more source

Novel PRMT5 Inhibitors for Treating Cancer [PDF]

ACS Medicinal Chemistry Letters, 2021
openaire   +2 more sources

Targeting PRMT5 to reshape the immune microenvironment and reverse Trop2 ADC resistance in triple-negative breast cancer. [PDF]

Cell Oncol (Dordr)
Kong J, Li M, Wang Y, Li M, Meng H, Ding J, Fan J, Wang T.   +7 more
europepmc   +1 more source

A methylation-dependent reader couples arginine methylation to S6K2 signaling in vivo. [PDF]

Sci Adv
Wang Y, Liu B, Fu R, He W, McGrail DJ, Xu H, Bedford MT.   +6 more
europepmc   +1 more source

PRMT7 at the crossroads of cancer progression and therapeutic targeting (Review). [PDF]

Oncol Rep
He Y, Lou J, Huang Y, Deng W, Cai X.
europepmc   +1 more source

Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam. [PDF]

Cancer Res Commun
Spielmann V, Buchloh J, Selcen S, Schneider C, Jansari S, Fang X, Duan N, Demirdizen E, Krauß L, Eggert J, Siegfried G, Fedou S, Lenz C, Wieland L, Conradi LC, Reichert M, Ellenrieder V, Ghadimi M, Grade M, Hessmann E, Khatib AM, Braun CJ, Wegwitz F, Saur D, Wirth M, Schneider G.   +25 more
europepmc   +1 more source

Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in <i>MTAP</i>-Null Non-Small Cell Lung Cancer. [PDF]

Biomolecules
Fu R, Wang Y, Rehman I, Bedford E, Sharif S, Nguyen ND, Powell RT, Adams A, Liu W, Wang S, He W, Lu Y, Liu B, Shah PA, Ahnert JR, Chen T, Peng W, Stephan CC, Liu X, Bedford MT, Xu H.   +20 more
europepmc   +1 more source

Dietary sulforaphane in cancer chemoprevention: epigenetic regulation and PRMT5-MEP50 complex inhibition-a systematic review. [PDF]

Front Pharmacol
Yan P, Sun C, Deng C.
europepmc   +1 more source